Biological impact of iberdomide in patients with active systemic lupus erythematosus.
Peter E LipskyRonald van VollenhovenThomas DörnerVictoria P WerthJoan T MerrillRichard A FurieMilan PetronijevicBenito Velasco ZamoraMaria MajdanFedra Irazoque-PalazuelosRobert TerbrueggenNikolay DelevMichael WeiswasserShimon KorishMark SternSarah HerseyYing YeAllison GaudyZhaohui LiuRobert GagnonShaojun TangPeter H SchaferPublished in: Annals of the rheumatic diseases (2022)
NCT03161483.